Efficacy of Oral Pediatric Patient-Controlled Premedication (Lollipop) of Midazolam and Ketamine vs Midazolam alone

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20171208002

Enrollment

120

Registered

2017-12-08

Start date

2018-01-08

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preoperative children premedication pedriatric midazolam ketamine lollipop

Interventions

ketamine lollipop,midazolam lollipop

midazolam&#45

midazolam 5 mg + ketamine 50 mg lollipop,midazolam 5 mg lollipop

Active Comparator Drug,Active Comparator Drug

Eligibility

Sex/Gender

All

Age

3 Years to 10 Years

Inclusion criteria

Inclusion criteria: preoperative children 3-10 year-old normal range of weight NPO more than 8 hr. ASA physical status 1-2 written informed consent obtained from the parent

Exclusion criteria

Exclusion criteria: Allergy to benzodiazepine or ketamine airway obstruction

Design outcomes

Primary

Measure	Time frame
sedation 30 minutes aftern drug administration sedation score	—

Secondary

Measure	Time frame
parent separation reaction 30 minutes after drug administration separation score,adverse effect at the end of operation Incidence of nausea/vomiting, desaturation	—

Countries

Thailand

Contacts

Public ContactNarut Ruananukun

Ramathibosi Hospital

aek_narut@hotmail.com+66815954599

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Efficacy of Oral Pediatric Patient&#45;Controlled Premedication (Lollipop) of Midazolam and Ketamine vs Midazolam alone